TTF2
Basic information
Region (hg38): 1:117060325-117107453
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (39 variants)
- not provided (19 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TTF2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 36 | 52 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 36 | 10 | 12 |
Variants in TTF2
This is a list of pathogenic ClinVar variants found in the TTF2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-117060369-A-G | not specified | Uncertain significance (Jul 09, 2021) | ||
1-117060509-G-A | Benign (Sep 11, 2018) | |||
1-117060524-G-A | not specified | Uncertain significance (Oct 04, 2022) | ||
1-117062405-C-G | not specified | Uncertain significance (Feb 12, 2024) | ||
1-117073677-A-G | not specified | Uncertain significance (Jul 12, 2022) | ||
1-117073701-C-T | not specified | Uncertain significance (Dec 21, 2023) | ||
1-117074974-C-A | not specified | Uncertain significance (Dec 17, 2023) | ||
1-117074976-A-G | Benign (Dec 31, 2019) | |||
1-117075060-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
1-117075062-G-A | not specified | Uncertain significance (May 10, 2023) | ||
1-117075065-C-G | Likely benign (May 25, 2018) | |||
1-117075091-G-C | not specified | Uncertain significance (Jul 26, 2022) | ||
1-117075168-A-G | not specified | Uncertain significance (Jan 24, 2023) | ||
1-117075222-A-G | Benign (May 31, 2018) | |||
1-117075232-T-G | not specified | Likely benign (Aug 10, 2021) | ||
1-117075281-T-C | not specified | Uncertain significance (Apr 13, 2022) | ||
1-117075365-C-A | not specified | Uncertain significance (Nov 17, 2022) | ||
1-117075376-A-C | not specified | Uncertain significance (Feb 12, 2024) | ||
1-117075402-G-C | Benign (Dec 31, 2019) | |||
1-117075419-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
1-117075435-A-T | not specified | Uncertain significance (Dec 06, 2021) | ||
1-117075441-C-T | not specified | Uncertain significance (May 16, 2022) | ||
1-117075473-G-A | not specified | Uncertain significance (Jun 26, 2023) | ||
1-117075531-G-A | not specified | Likely benign (Jan 10, 2022) | ||
1-117075557-C-G | not specified | Uncertain significance (Oct 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TTF2 | protein_coding | protein_coding | ENST00000369466 | 23 | 47151 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00e-22 | 0.769 | 125620 | 0 | 128 | 125748 | 0.000509 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.807 | 561 | 617 | 0.909 | 0.0000320 | 7548 |
Missense in Polyphen | 175 | 191.47 | 0.91396 | 2366 | ||
Synonymous | -0.275 | 237 | 232 | 1.02 | 0.0000120 | 2273 |
Loss of Function | 2.32 | 45 | 65.2 | 0.690 | 0.00000355 | 746 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00129 | 0.00129 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000767 | 0.000761 |
Finnish | 0.000186 | 0.000185 |
European (Non-Finnish) | 0.000573 | 0.000571 |
Middle Eastern | 0.000767 | 0.000761 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000815 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: DsDNA-dependent ATPase which acts as a transcription termination factor by coupling ATP hydrolysis with removal of RNA polymerase II from the DNA template. May contribute to mitotic transcription repression. May also be involved in pre-mRNA splicing. {ECO:0000269|PubMed:10455150, ECO:0000269|PubMed:12927788, ECO:0000269|PubMed:15125840, ECO:0000269|PubMed:9748214}.;
- Pathway
- Thyroid hormone synthesis - Homo sapiens (human);Human Thyroid Stimulating Hormone (TSH) signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.0955
Intolerance Scores
- loftool
- 0.155
- rvis_EVS
- 1.43
- rvis_percentile_EVS
- 95.03
Haploinsufficiency Scores
- pHI
- 0.562
- hipred
- N
- hipred_score
- 0.383
- ghis
- 0.571
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.861
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ttf2
- Phenotype
Gene ontology
- Biological process
- DNA-templated transcription, termination;termination of RNA polymerase II transcription;mRNA processing;RNA splicing
- Cellular component
- spliceosomal complex;cytosol;transcription elongation factor complex
- Molecular function
- DNA binding;helicase activity;protein binding;ATP binding;DNA-dependent ATPase activity;zinc ion binding